文献速递垂体与肾上腺疾病

患者管理方法:嗜铬细胞瘤或交感神经性副神经节瘤患者的围手术期管理

Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

嗜铬细胞瘤和交感神经性副神经节瘤(PPGL)是罕见的嗜铬细胞肿瘤,手术切除是唯一治愈手段,但手术风险高,需由专业多学科团队管理。本文讨论术前药物准备的证据及利弊,并指出该领域的不确定性与争议。

要点

  • PPGL手术切除是唯一治愈手段,但属高风险手术,需充分术前抗高血压药物准备。
  • 管理应由经验丰富的中心的多学科团队完成。
  • 术前药物准备的证据及利弊仍有争议,存在不确定性。

核心结论

  • PPGL手术切除是唯一治愈手段,但为高风险手术,需最佳抗高血压药物预处理联合先进手术与麻醉技术。
  • 管理复杂,应由经验丰富的中心的多学科团队完成。

研究设计与样本

  • 本文为患者管理方法类综述,讨论术前药物准备的证据及利弊,并探讨不确定性与争议。

主要发现

  • PPGL是起源于肾上腺髓质和交感神经副神经节的罕见嗜铬细胞肿瘤,具有合成和释放儿茶酚胺的能力。
  • 近年来PPGL发病率增加。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pheochromocytomas and sympathetic paraganglioma (PPGL) are rare chromaffin cell tumors originating in the adrenal medulla and sympathetic paraganglia, respectively, which share the capacity to synthesize and release catecholamines. The incidence of PPGL has increased in recent years. Surgical resection is the only curative treatment for PPGL. Management of patients with PPGL is complex and should be done by a specialized multidisciplinary team in centers with broad expertise. Surgical resection of a PPGL is a high-risk procedure for which optimal pretreatment with antihypertensive drugs is required in combination with state-of-the-art surgical procedures and anesthesiological techniques. In this article we discuss the underlying evidence and the pros and cons of presurgical medical preparation. Finally, the areas of uncertainty and controversies in this field are addressed.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Berends AMA, Kerstens MN, Lenders JWM, et al. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2020. PMID: 32726444. doi:10.1210/clinem/dgaa441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。